Use And Importance Of Self-Medication Assessed

24 July 1994

Results of new research carried out by SRA show that 68% of consumers agree that they are taking greater responsibility for treating minor illness themselves, rather than going to a doctor, Colston Herbert, president of Sterling Health Europe and newly-elected president of the Proprietary Association of Great Britain, told the recent 30th annual conference of the European Proprietary Medicines Manufacturers' Association.

According to the SRA study, said Mr Herbert, the prompts for a visit to a general practitioner were reported as a worsening of symptoms (70%), having the symptom for a few days (19%) and that a medicine purchased did not work after three days (10%). 70% of respondents said they would be less likely to go to their GP if they had information about how to self-treat common ailments.

Consumers were also asked when they would use the pharmacist for advice. The main reasons were to choose the right medicine (37%) and to save time by not going to the doctor (25%). Those using the pharmacist to save time were predominantly in the 21-54 age range, both males and females, and in employment.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight